ImmunityBio, Inc. (IBRX) — Insider Trading & SEC Form 4 Filings
This page tracks SEC Form 4 insider transactions for ImmunityBio, Inc. (IBRX). Officers, directors, and 10%+ beneficial owners are required to report their IBRX trades to the SEC within two business days.
- 21 recent acquisitions ($25,223,496)
- 29 recent disposals ($5,091,088)
- 50 filings in this window
Recent IBRX insider transactions
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Mar 31, 2026 | SOON-SHIONG PATRICK | Director, Officer, 10%+ | Buy | 4,606,596 | $24,999,996 |
| Feb 24, 2026 | Simon Barry J. | Director | Sell | 75,000 | $900,788 |
| Feb 10, 2026 | SOON-SHIONG PATRICK | Director, Officer, 10%+ | Buy | 274,122 | — |
| Feb 10, 2026 | Sachs David C. | Officer | Sell | 82,236 | — |
| Feb 10, 2026 | Adcock Richard | Director, Officer | Sell | 274,122 | — |
| Feb 10, 2026 | LAUER REGAN J | Officer | Buy | 5,482 | — |
| Feb 10, 2026 | LAUER REGAN J | Officer | Sell | 2,257 | $15,641 |
| Feb 10, 2026 | SOON-SHIONG PATRICK | Director, Officer, 10%+ | Sell | 118,560 | $821,621 |
| Feb 10, 2026 | LAUER REGAN J | Officer | Sell | 5,482 | — |
| Feb 10, 2026 | SOON-SHIONG PATRICK | Director, Officer, 10%+ | Sell | 274,122 | — |
| Feb 10, 2026 | Adcock Richard | Director, Officer | Buy | 274,122 | — |
| Feb 10, 2026 | Sachs David C. | Officer | Buy | 82,236 | — |
| Feb 10, 2026 | Sachs David C. | Officer | Sell | 42,643 | $295,516 |
| Feb 10, 2026 | Adcock Richard | Director, Officer | Sell | 140,048 | $970,533 |
| Jan 20, 2026 | Selecky Christobel | Director | Sell | 25,000 | — |
| Jan 20, 2026 | Simon Barry J. | Director | Sell | 76,967 | $503,364 |
| Jan 20, 2026 | Simon Barry J. | Director | Sell | 75,000 | $590,933 |
| Jan 20, 2026 | Selecky Christobel | Director | Sell | 25,000 | $187,650 |
| Jan 20, 2026 | Selecky Christobel | Director | Buy | 25,000 | $74,500 |
| Jan 16, 2026 | Selecky Christobel | Director | Sell | 50,000 | — |
Frequently asked questions
- What is insider trading for IBRX?
- Insider trading refers to SEC Form 4 filings by officers, directors, and 10%+ owners of ImmunityBio, Inc.. These are public disclosures of legal transactions — open-market buys, sells, option exercises, and gifts — required within two business days of the trade.
- How many insider transactions has IBRX had recently?
- The most recent 50 insider filings for IBRX are shown below, with 21 acquisitions and 29 disposals in this window. Data is sourced directly from SEC EDGAR.
- Where does this insider data come from?
- All insider data is parsed from original SEC Form 4, Form 3, and Form 5 XML filings on EDGAR. Filings marked as amended or superseded are excluded from summary counts.